You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers
The stock market has been on a solid upward trajectory recently, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) has largely been leading the way. With so many stocks in high-growth areas like technology, the Nasdaq has been at the center of key trends driving stocks back higher after 2022's bear market. Monday morning brought a brief pause to the rally, but futures on the Nasdaq were still up slightly in the early morning session.
A couple of biotech stocks stood out as big winners in the Nasdaq on Monday morning. Both Argenx (NASDAQ: ARGX) and BridgeBio Pharma (NASDAQ: BBIO) moved sharply higher, as both companies had good news to announce that inspired shareholders to be more optimistic about what the future will bring.
Shares of Argenx were 27% higher in premarket trading on Monday morning. The Dutch biotech company announced favorable results in a key clinical trial, and investors were pleased with the implications for the company's future.
Source Fool.com
